argenx Stock (NASDAQ:ARGX), Quotes and News Summary

Q: What sector and industry does argenx (ARGX) operate in?

argenx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

argenx Stock (NASDAQ: ARGX) stock price, news, charts, stock research, profile.

Open	$360.380
Close	$360.230
Volume / Avg.	331.571K / 306.017K
Day Range	357.550 - 362.535
52 Wk Range	327.725 - 550.760
Market Cap	$21.409B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	-
Days to Cover	3.66

Recent News

Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy

Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising anti-BCMA CAR-T therapy offering deeper, longer-lasting efficacy than current standards. Analysts project substantial market capture and peak sales potential.

Vandana Singh

Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Argen X SE

Sector

Health Care

Industry

Biotechnology

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimm...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy argenx (ARGX) stock?

You can purchase shares of argenx (NASDAQ: ARGX) through any online brokerage.

View our list of the best stock brokerages.

Who are argenx's (ARGX) competitors?

Other companies in argenx’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for argenx (ARGX) stock?

The latest price target for argenx (NASDAQ: ARGX) was reported by Wedbush on Thursday, April 18, 2024. The analyst firm set a price target for 521.00 expecting ARGX to rise to within 12 months (a possible 44.63% upside). 64 analyst firms have reported ratings in the last year.

Current Stock Price for argenx (ARGX)?

The stock price for argenx (NASDAQ: ARGX) is $360.23 last updated April 19, 2024 at 4:00 PM EDT.

Does argenx (ARGX) pay a dividend?

There are no upcoming dividends for argenx.

When is argenx (NASDAQ:ARGX) reporting earnings?

argenx’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is argenx (ARGX) going to split?

There is no upcoming split for argenx.

What sector and industry does argenx (ARGX) operate in?

argenx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-